ArticleJournal of clinical medicine2022

Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients.

Federica Fogacci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.